Reserpine And Hydrochlorothiazide

   
Google
 
Web NewDrugInformation.com

Reserpine And Hydrochlorothiazide


Drug - Reserpine And Hydrochlorothiazide
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Hydrochlorothiazide; Reserpine
Multiple ingredients are in alphabetical order.

Strength - 50MG;0.125MG
The potency of the active ingredient(s), Hydrochlorothiazide; Reserpine. May repeat for multiple part products.

Applicant - BARR
The firm name holding legal responsibility for Reserpine And Hydrochlorothiazide. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 084579
The FDA assigned number to Reserpine And Hydrochlorothiazide. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Reserpine And Hydrochlorothiazide. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Reserpine And Hydrochlorothiazide was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Reserpine And Hydrochlorothiazide. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Reserpine And Hydrochlorothiazide is in. Format is RX, OTC, DISCN.

Applicant Full Name - Barr Laboratories Inc
The full name of the firm holding legal responsibility for the new application of Reserpine And Hydrochlorothiazide.

Reserpine And Hydrochlorothiazide